Insulet
PODD
#1851
Rank
NZ$19.48 B
Marketcap
NZ$281.34
Share price
-0.20%
Change (1 day)
-41.56%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

Earnings for Insulet (PODD)

Earnings in 2026 (TTM): NZ$0.80 Billion

According to Insulet's latest financial reports the company's current earnings are NZ$2.90 Billion. In 2025 the company made an earning of NZ$0.67 Billion, an increase over its 2024 earnings that were of NZ$0.58 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Insulet from 2006 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) NZ$0.80 B18.93%
2025 NZ$0.67 B16.3%
2024 NZ$0.58 B36.76%
2023 NZ$0.42 B481.9%
2022 NZ$73.33 M-45.24%
2021 NZ$0.13 B43.35%
2020 NZ$93.41 M18.51%
2019 NZ$78.82 M41.16%
2018 NZ$55.84 M-711.95%
2017 -NZ$9.13 Million-56.85%
2016 -NZ$21.15 Million-79.31%
2015 -NZ$0.11 Billion63.85%
2014 -NZ$62.4 Million31.04%
2013 -NZ$47.62 Million-21.96%
2012 -NZ$61.02 Million
2010 -NZ$58.2 Million-42.38%
2009 -NZ$0.11 Billion-33.56%
2008 -NZ$0.16 Billion65.93%
2007 -NZ$91.62 Million209.75%
2006 -NZ$29.58 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$44.20 B 5,436.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$13.84 B 1,634.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
NZ$11.65 B 1,360.14%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Eli Lilly
LLY
NZ$52.95 B 6,533.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Tandem Diabetes Care
TNDM
-NZ$0.17 Billion-120.90%๐Ÿ‡บ๐Ÿ‡ธ USA
ICU Medical
ICUI
NZ$0.16 B-79.14%๐Ÿ‡บ๐Ÿ‡ธ USA
DexCom
DXCM
NZ$2.07 B 160.08%๐Ÿ‡บ๐Ÿ‡ธ USA